0001213900-21-034010.txt : 20210624
0001213900-21-034010.hdr.sgml : 20210624
20210624175200
ACCESSION NUMBER: 0001213900-21-034010
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210622
FILED AS OF DATE: 20210624
DATE AS OF CHANGE: 20210624
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ganjei James Kelly
CENTRAL INDEX KEY: 0001767300
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38793
FILM NUMBER: 211043950
MAIL ADDRESS:
STREET 1: 10609 RIVER OAKS LANE
CITY: POTOMAC
STATE: MD
ZIP: 20859
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inmune Bio, Inc.
CENTRAL INDEX KEY: 0001711754
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 475205835
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1200 PROSPECT STREET
STREET 2: SUITE 525
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 8589643720
MAIL ADDRESS:
STREET 1: 1200 PROSPECT STREET
STREET 2: SUITE 525
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
ownership.xml
X0306
4
2021-06-22
0
0001711754
Inmune Bio, Inc.
INMB
0001767300
Ganjei James Kelly
C/O INMUNE BIO INC.,
1200 PROSPECT STREET, SUITE 525
LA JOLLA,
CA
92037
1
0
0
0
Option (right to buy)
17.49
2021-06-22
4
A
0
19025
0
A
2031-06-21
Common Stock
19025
19025
D
Each Option represents a right to receive one share of common stock of INmune Bio, Inc.
Options granted pursuant to the Company's 2021 Stock Incentive Plan. These Options vest on a pro rata quarterly basis over three years such that all options to purchase the 19,025 shares will have vested on the third anniversary of the grant date.
/s/ James Kelly Ganjei
2021-06-24